Jnana Therapeutics to Speak at RBC Capital's Healthcare Conference

28 June 2024

BOSTON, May 08, 2024 -- Jnana Therapeutics, a clinical-stage biotechnology company, utilizes its advanced chemoproteomics platform to develop treatments for difficult-to-drug targets. The company announced that Joanne Kotz, Ph.D., Co-founder and Chief Executive Officer, will provide a corporate overview at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 2:05 p.m. ET.

About Jnana Therapeutics:
Jnana Therapeutics is at the forefront of clinical-stage biotechnology, using its next-generation RAPID chemoproteomics platform to create medicines for targets that have been challenging to drug. The primary focus of the company is to develop first- and best-in-class therapies to address a broad spectrum of diseases, with particular attention to rare and immune-mediated conditions.

One of Jnana's significant advancements is its lead program, JNT-517, which targets an allosteric site on the phenylalanine transporter SLC6A19. This program offers a pioneering oral treatment for Phenylketonuria (PKU), a rare genetic metabolic disorder. JNT-517 is poised to be a first-in-class therapy, representing a promising development in the treatment of this challenging condition.

Operating out of Boston, Jnana Therapeutics combines the expertise of scientific leaders in small molecule drug discovery and development. The company boasts a highly experienced management team and is supported by leading life science investors including Bain Capital Life Sciences, RA Capital Management, Polaris Partners, Versant Ventures, Avalon Ventures, Pfizer Ventures, and AbbVie Ventures.

Jnana Therapeutics integrates cutting-edge science with a robust infrastructure to push the boundaries of medical discovery and deliver novel therapies for diseases with high unmet needs. 

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!